Global /United Kingdom /Healthcare /Drug Manufacturers - General /VLG
chevron_leftBack
Venture Life Group plc logo

Venture Life Group plc

VLG
LSE: VLG Delayed
58GBX -1%
0.7786 USD
As of 5 June 2026, Venture Life Group plc has a market cap of $95.78M USD, ranking #25881 globally and #594 in the United Kingdom. It ranks #2324 in the Healthcare sector, and #838 in the Drug Manufacturers - General industry.
Global Rank
25881
Country Rank
594
Sector Rank
2324
Industry Rank
838
Key Stats
Market Cap
$95.78MUSD
71.39M GBP
Enterprise Value
$50.87MUSD
37.89M GBP
Revenue (TTM)
$47.18MUSD
35.17M GBP
EBITDA (TTM)
$7.05MUSD
5.25M GBP
Net Income (TTM)
$8.22MUSD
6.13M GBP
EBITDA Margin
15%
Profit Margin
17%
PE Ratio
11.7
Forward PE
14.3
PS Ratio
2.0
PB Ratio
0.9
EV/EBITDA
6.8
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jeremy Anthony Randall open_in_new
Employees
43
Founded
2005
Website
venture-life.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-1% -9.8% -14% -14% 6.5% 45%

News

Loading...

Markets

Exchange Ticker Price
London Stock Exchange
MIC: XLON
PRIMARY
VLG
Venture Life Group PLC
ISIN: GB00BFPM8908
Shares Out.:
121.828M1 Shares Float: 103.629M2
TV:
SA:
YF:
GF:
BA:
VLG
MS:
58 GBX
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Venture Life Group plc

Venture Life Group plc develops and commercializes healthcare products in the United Kingdom. The company offers oral healthcare products, including mouthwash, toothpaste, breath freshening capsules, and dental accessories under UltraDEX and Dentyl Dual Action brands; and proctology products, such as Procto-eze Plus range for treating the discomfort caused by haemorrhoids. It also provides dermatology products comprising Myco Clear, a fungal nail cleanser and solution brand; Rosa calma for normalizing and controlling the signs and symptoms related to rosacea; Bioscalin for the cosmetic treatment and prevention of hair loss, hair thinning, and baldness; and skincare solutions under the brand Lubatti. In addition, the company offers women’s healthcare products, including BV treatment gel and pessaries; intimate daily wash and soothing cream; moisture gel and plus pessaries; and thrush cream under Balance Activ name. Further, it provides glucose management products, such as Lift Glucose shots and tablets for the immediate treatment of hypoglycaemia and preventing hypos; Glucogel for the treatment of hypoglycaemia. Additionally, the company offers ENT care products comprising Earol, for the removal of ear wax; EarolSwim, an invisible ear plugs for protecting the ears from water ingress; and Baby Earol, an ear spray for babies under the Earol and EarolSwim brands. It also provides oncology support products, such as Pomi-T for the management of prostate-specific antigen levels in prostate cancer; Gelclair, a muco-adhesive oral rinse for the treatment of Oral Mucositis; and Xonrid, a hyaluronic acid-based topical gel, for the prevention and treatment of radiation-induced dermatitis. The company operates in Germany, the Netherlands, France, Sweden, Denmark, Lithuania, rest of Europe, the United States, Canada, Brazil, Ireland, and internationally. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.

Similar Companies

Industry: Drug Manufacturers - General (United Kingdom)
Name
Market Cap diff.
PE
AZN
$289.25B
215.59B GBP
302K%
27.6
GSK
$108.62B
80.96B GBP
113K%
14.6
HLN
$41.88B
31.22B GBP
44K%
19.0
ROIV
$19.69B
20K%
-
$6.1B
6K%
-
$4.07B
4K%
58.4
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
795K%
38.1
JNJ
$547.28B
571K%
26.4
ABBV
$360.63B
376K%
97.4
$323.4B
256.25B CHF
338K%
19.9
NOVN
$276.26B
218.9B CHF
288K%
20.5
MRK
$274.03B
286K%
15.1
chevron_leftBack